|
WO2005040189A1
|
|
Novel dammarane sapogenins and their use as anti-cancer agents
|
|
WO2005034963A1
|
|
USE OF GINSENOSIDES Rh2 & Rg3, AND AGLYCON GINSENOSIDES FOR THE PREVENTION OF CANCER
|
|
AU2003291896A1
|
|
Saponins and sapogenins for use in combination therapy for cancer
|
|
WO2004056371A1
|
|
Use of aglycon protopanaxatriol in cancer therapy
|
|
WO2004056372A1
|
|
Use of aglycon protopanaxadiol in cancer therapy
|
|
AU2003233733A1
|
|
Compositions for cancer therapy saponins or sapogenins
|
|
CA2431806A1
|
|
Compositions for cancer therapy
|
|
TW200412987A
|
|
Use of aglycon protopanaxatriol in cancer therapy
|
|
TW200412985A
|
|
Use of aglycon protopanaxadiol in cancer therapy
|
|
EP1429778A1
|
|
Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents
|
|
CA2390290A1
|
|
Protopanaxadiol and protopanaxatriol and their use as anti-cancer agents
|
|
US6888014B2
|
|
Dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
|
|
US6949523B2
|
|
Aglycon dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
|
